Page last updated: 2024-09-05

sorafenib and Pregnancy

sorafenib has been researched along with Pregnancy in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Alonso, JC; Burgos, R; Casans, I; Espinoza, N; Fuster, D; González, FM; Oyagüez, I; Rodríguez, A; Sánchez, N; Williams, AO1
Aly, A; Benavente, F; Henriques, C; Kim, A; Malangone-Monaco, E; Noxon, V1
Azem, F; Fouks, Y; Goaz, S; Hasson, Y; Malcov, M; Sheiman, V1
Beijnen, JH; de Vries, N; Schinkel, AH; Sparidans, RW; Tang, SC; Wagenaar, E1
Alvares, C; Chakraborty, M; Conner, C; Gosrani, D; Mahdi, AJ; Rayment, R; Rees, A; Wilson, K1
Chen, H; Chen, HJ; Huang, Y; Li, X; Wei, Q; Wu, YJ; Xie, X; Yang, YR; Zeng, H; Zhou, Q; Zhu, YC1

Reviews

1 review(s) available for sorafenib and Pregnancy

ArticleYear
Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review.
    BMC gastroenterology, 2022, Jul-02, Volume: 22, Issue:1

    Topics: Canada; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Female; Humans; Liver Neoplasms; Microspheres; Pregnancy; Sorafenib

2022

Other Studies

5 other study(ies) available for sorafenib and Pregnancy

ArticleYear
Treatment patterns and direct medical costs among patients with advanced hepatocellular carcinoma.
    Current medical research and opinion, 2020, Volume: 36, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Costs and Cost Analysis; Female; Health Care Costs; Humans; Liver Neoplasms; Male; Middle Aged; Pregnancy; Sorafenib; United States

2020
Fertility preservation and PGT-M in women with familial adenomatous polyposis-associated desmoid tumours.
    Reproductive biomedicine online, 2021, Volume: 43, Issue:4

    Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Adult; Antineoplastic Agents; Female; Fertility Preservation; Fibromatosis, Aggressive; Humans; Oocyte Retrieval; Pregnancy; Preimplantation Diagnosis; Retrospective Studies; Sorafenib; Young Adult

2021
Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) gene dosage on plasma pharmacokinetics and brain accumulation of dasatinib, sorafenib, and sunitinib.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 346, Issue:3

    Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Brain; Dasatinib; DNA, Complementary; Female; Gene Dosage; Half-Life; Indoles; Male; Maternal-Fetal Exchange; Mice; Mice, Knockout; Niacinamide; Phenylurea Compounds; Pregnancy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Real-Time Polymerase Chain Reaction; RNA; Sex Characteristics; Sorafenib; Sunitinib; Thiazoles

2013
Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes.
    British journal of haematology, 2018, Volume: 180, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Female; Humans; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pregnancy; Pregnancy Complications, Neoplastic; Sorafenib; Treatment Outcome

2018
Primitive neuroectodermal tumor of the kidney with inferior vena cava tumor thrombus during pregnancy response to sorafenib.
    Chinese medical journal, 2010, Aug-05, Volume: 123, Issue:15

    Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Female; Humans; Kidney Neoplasms; Neuroectodermal Tumors, Primitive; Niacinamide; Phenylurea Compounds; Pregnancy; Pyridines; Radiography; Sorafenib; Thrombosis; Vena Cava, Inferior

2010